Vice President, Chemistry, Manufacturing & Control (CMC)

Paddy Shivanand, Ph.D

Dr. Shivanand serves as the Vice President of Chemistry, Manufacturing & Control (CMC) for Kovina Therapeutics. Her background includes a broad range of early and late-stage product development experiences including drug substance and drug product development, formulation and process development, analytical development, and CMC quality and regulatory topics.

Dr. Shivanand has more than 20 years of experience in pharmaceutical product development, having started her career with the product development group at ALZA Corporation, and Johnson & Johnson. During her work at ALZA and Johnson & Johnson, she was responsible for formulation development, process development, and product optimization activities for multiple products, including the oral controlled release product CONCERTA®.  In addition, Dr. Shivanand co-founded a CMC consulting firm supporting multiple drug discovery companies prior to serving as Vice President of CMC at Expansion Therapeutics.

During her career, she has worked on the development of more than 25 molecules for various routes of administration, leading to several successful regulatory submissions and product approvals. She is an inventor on 9 issued patents and has several peer reviewed publications. Dr. Shivanand also serves as Adjunct Faculty at Purdue University in the Biotechnology Innovation and Regulatory Science program.

Dr. Shivanand received her Bachelor of Pharmacy from the University of Mumbai and her M.S. and Ph.D. in Pharmaceutical Sciences, both from the University of Cincinnati.

Back to Leadership
Paddy Shivanand, Ph.D